A Form 4 filed on September 3, 2026 reports that Akinbolade Oyegunwa, Executive Vice President, Chief Information Officer and Chief Technology Officer of Labcorp Holdings Inc. (NYSE:LH), acquired 750 Restricted Stock Units on September 1, 2026.
Director Charles E. Ryan filed a Form 4 with the SEC on September 3, 2026, reporting the acquisition of 1,352 restricted share units in Nebius Group N.V. (NASDAQ:NBIS) on September 1, 2026.
Director Matthew Robert Weigand filed a Form 4 with the SEC on September 2, 2026, disclosing the acquisition of restricted share units in Nebius Group N.V. (NASDAQ:NBIS) on September 1, 2026.
Saba Capital Management, L.P. filed a Form 4 on September 3, 2026, disclosing two open-market sales of common stock in BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) on September 1 and September 2, 2026.
A Form 4 filed on September 3, 2026, reported that Milton Mayo Morris, a director of Nordson Corp (NASDAQ:NDSN), sold 156 shares of common stock on September 2, 2026.
● Genelux is a clinical-stage biopharmaceutical company developing oncolytic virus immunotherapies for cancer.
● TuHURA Biosciences is a clinical-stage immuno-oncology company developing therapies aimed at overcoming resistance to cancer immunotherapies.
● Kimberly-Clark manufactures personal-care and tissue products sold under well-known consumer brands globally.
● Kratos Defense & Security Solutions develops unmanned aerial systems, satellite communications, and other defense and space technologies.
● LadderCapitalis aCommercial Real Estatefinance company structured as a REIT, originating and investing in commercialMortgageloans and securities.